- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02928653
Beverage Consumption and Fine Motor Control (LCS)
March 19, 2019 updated by: Richard Mattes, Purdue University
The Effect of Low Calorie Sweetener Consumption on Body Weight, Body Composition, Appetite, and Energy Intake
The aim of this study will be to compare the effects of daily consumption of aspartame, rebaudioside a, saccharin, sucralose, and sucrose on body weight and composition in a standardized protocol.
The investigators hypothesize that individual low calorie sweeteners (consumed in a beverage) differ from each other in promoting weight loss and decreased fat mass (without energy restriction or dietary guidance) based on their chemical structure.
Study Overview
Study Type
Interventional
Enrollment (Actual)
187
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Indiana
-
West Lafayette, Indiana, United States, 47907
- Purdue University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- BMI between 25-40 kg/M2
- Non or rare users of LCS
- Willing to consume large volumes of beverages daily
Exclusion Criteria:
- Weight change > 3kg in the last year
- Plan to initiate a new diet plan in the next 6 months
- Exhibit eating restraint
- Pregnant/lactating
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Sucrose Sweetened Beverage
100-140 g sucrose/day
|
Participants will receive 1.25 - 1.75 L of sweetened beverage a day for 12 weeks
|
Experimental: Aspartame Sweetened Beverage
0.541-0.757
g aspartame Sweetened Beverage/day
|
Participants will receive 1.25 - 1.75 L of sweetened beverage a day for 12 weeks
|
Experimental: Saccharin Sweetened Beverage
0.300-0.455
g saccharin Sweetened Beverage/day
|
Participants will receive 1.25 - 1.75 L of sweetened beverage a day for 12 weeks
|
Experimental: Sucralose Sweetened Beverage
0.167-0.233
g sucralose Sweetened Beverage/day
|
Participants will receive 1.25 - 1.75 L of sweetened beverage a day for 12 weeks
|
Experimental: Rebaudioside A Sweeteened Beverage
0.250-0.350
g rebaudioside A Sweetened Beverage/day
|
Participants will receive 1.25 - 1.75 L of sweetened beverage a day for 12 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Body Weight
Time Frame: 12 weeks
|
12 weeks
|
|
Body Composition
Time Frame: 12 weeks
|
Duel emission X-ray absorbtiometry
|
12 weeks
|
Energy Intake
Time Frame: 12 weeks
|
24 hr Dietary Recall
|
12 weeks
|
Appetite
Time Frame: 12 weeks
|
24 hr visual analog scale appetite
|
12 weeks
|
Energy Expenditure
Time Frame: 12 weeks
|
accelerometer
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2015
Primary Completion (Actual)
February 1, 2018
Study Completion (Actual)
December 1, 2018
Study Registration Dates
First Submitted
October 5, 2016
First Submitted That Met QC Criteria
October 6, 2016
First Posted (Estimate)
October 10, 2016
Study Record Updates
Last Update Posted (Actual)
March 21, 2019
Last Update Submitted That Met QC Criteria
March 19, 2019
Last Verified
March 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 055-044
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Body Weight
-
University of PittsburghNational Heart, Lung, and Blood Institute (NHLBI)RecruitingWeight Loss | Weight, BodyUnited States
-
Oslo University HospitalMayo Clinic; Sorlandet Hospital HF; The Hospital of Vestfold; University of TwenteActive, not recruiting
-
Fred Hutchinson Cancer CenterCompletedWeight Loss | Weight, BodyUnited States
-
Pusan National University HospitalCompletedWeight Change, Body
-
Erik Ramirez LopezCompletedWeight Loss | Body CompositionMexico
-
Xinhua Hospital, Shanghai Jiao Tong University...Not yet recruiting
-
University of TennesseeMayo Clinic; National Institute of Diabetes and Digestive and Kidney Diseases...CompletedSmoking Cessation | Weight Change, BodyUnited States
-
University of LeedsDietary Assessment LtdRecruitingWeight Loss | Colorectal Surgery | Weight Change, Body | Gastroenterology SurgeryUnited Kingdom
-
Virta HealthCompleted
-
University of CopenhagenCompleted
Clinical Trials on Beverage
-
Unilever R&DCompletedSatiety | AppetiteUnited Kingdom
-
University of CopenhagenCarlsberg Breweries A/SCompletedInsulin Resistance | Alcohol ConsumptionDenmark
-
Old Dominion UniversityRecruitingAnomalies GastrointestinalUnited States
-
Old Dominion UniversityCompletedImpaired ThermoregulationUnited States
-
University of FloridaHeermann Anesthesia FoundationCompleted
-
University of ExeterCompleted
-
Unilever R&DEurofins OptimedCompleted
-
GlaxoSmithKlineCompleted
-
PepsiCo Global R&DGlycemic Index Laboratories, IncCompleted
-
University of CopenhagenCompletedObesity | Cardiovascular Disease | Type 2 DiabetesDenmark